Lanthanide-Doped SPIONs Bioconjugation with Trastuzumab for Potential Multimodal Anticancer Activity and Magnetic Hyperthermia

Overview

Journal Nanomaterials (Basel)

Date 2020 Feb 13

PMID 32046284

Citations 10

Authors

Weronika Gaweda

Magdalena Osial

Michal Zuk

Marek Pekala

Aleksander Bilewicz

Pawel Krysinski

Affiliations

Soon will be listed here.

Abstract

Iron oxide-based nanoparticles have been modified in their core with holmium(III) in an amount affecting only slightly their magnetic properties. Nanoparticles were conjugated covalently with biomolecule of trastuzumab (Herceptin), the monoclonal antibody that recognizes cancer cells overexpressing HER2 receptors targeting such nanoparticles to the specified tumor tissues. Systematic studies of Ho-doped bioconjugates were carried out as a preliminary step for future replacement of 'cold' Ho with Ho radionuclide, emitting 'soft' beta(-) radiation for possible targeted radionuclide therapy. Physicochemical properties of the obtained bioconjugates were subsequently tested for use in magnetic hyperthermia, considered as an effective, low-invasiveness anticancer therapy. With such a system we expect to achieve both: active targeting and multimodal action by simultaneous internal and localized irradiation and magnetic hyperthermia of specific cancers.

Citing Articles

Synthesis of Magnetic Luminescent Nanoparticle FeO@LaF:Eu,Ag@APTES@β-CD, a Potential Carrier of Antimicrobial Drug Ciprofloxacin.

Swain S, Phaomei G, Dash S, Tripathy S Indian J Microbiol. 2024; 64(4):1637-1645.

PMID: 39678968 PMC: 11645346. DOI: 10.1007/s12088-024-01202-z.

Au-Coated Superparamagnetic Iron Oxide Nanoparticles for Dual Magnetic Hyperthermia and Radionuclide Therapy of Hepatocellular Carcinoma.

Gharibkandi N, Zuk M, Muftuler F, Wawrowicz K, Zelechowska-Matysiak K, Bilewicz A Int J Mol Sci. 2023; 24(6).

PMID: 36982357 PMC: 10049102. DOI: 10.3390/ijms24065282.

Surface modification of magnetic nanoparticles by bacteriophages and ionic liquids precursors.

Dzialak P, Syczewski M, Blachowski A, Kornaus K, Bajda T, Zych L RSC Adv. 2023; 13(2):926-936.

PMID: 36686914 PMC: 9811242. DOI: 10.1039/d2ra06661k.

Multifunctional Nanoparticles Based on Iron Oxide and Gold-198 Designed for Magnetic Hyperthermia and Radionuclide Therapy as a Potential Tool for Combined HER2-Positive Cancer Treatment.

Zuk M, Podgorski R, Ruszczynska A, Ciach T, Majkowska-Pilip A, Bilewicz A Pharmaceutics. 2022; 14(8).

PMID: 36015306 PMC: 9415738. DOI: 10.3390/pharmaceutics14081680.

Preliminary Evaluation of Iron Oxide Nanoparticles Radiolabeled with Ga and Lu as Potential Theranostic Agents.

Salvanou E, Kolokithas-Ntoukas A, Liolios C, Xanthopoulos S, Paravatou-Petsotas M, Tsoukalas C Nanomaterials (Basel). 2022; 12(14).

PMID: 35889715 PMC: 9321329. DOI: 10.3390/nano12142490.

References

Lee N, Hyeon T . Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem Soc Rev. 2011; 41(7):2575-89. DOI: 10.1039/c1cs15248c. View

Majeed M, Lu Q, Yan W, Li Z, Hussain I, Tahir M . Highly water-soluble magnetic iron oxide (FeO) nanoparticles for drug delivery: enhanced in vitro therapeutic efficacy of doxorubicin and MION conjugates. J Mater Chem B. 2020; 1(22):2874-2884. DOI: 10.1039/c3tb20322k. View

Hervault A, Thanh N . Magnetic nanoparticle-based therapeutic agents for thermo-chemotherapy treatment of cancer. Nanoscale. 2014; 6(20):11553-73. DOI: 10.1039/c4nr03482a. View

Rong L, Zhou S, Liu X, Li A, Jing T, Liu X . Trastuzumab-modified DM1-loaded nanoparticles for HER2 breast cancer treatment: an in vitro and in vivo study. Artif Cells Nanomed Biotechnol. 2017; 46(8):1708-1718. DOI: 10.1080/21691401.2017.1391821. View

Kandasamy G, Maity D . Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics. Int J Pharm. 2015; 496(2):191-218. DOI: 10.1016/j.ijpharm.2015.10.058. View

Smith B, Roder P, Zhou X, Pauzauskie P . Nanoscale materials for hyperthermal theranostics. Nanoscale. 2015; 7(16):7115-26. PMC: 4830465. DOI: 10.1039/c4nr06164k. View

Wu W, Wu Z, Yu T, Jiang C, Kim W . Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications. Sci Technol Adv Mater. 2016; 16(2):023501. PMC: 5036481. DOI: 10.1088/1468-6996/16/2/023501. View

Lehenberger S, Barkhausen C, Cohrs S, Fischer E, Grunberg J, Hohn A . The low-energy β(-) and electron emitter (161)Tb as an alternative to (177)Lu for targeted radionuclide therapy. Nucl Med Biol. 2011; 38(6):917-24. DOI: 10.1016/j.nucmedbio.2011.02.007. View

Iacovita C, Florea A, Dudric R, Pall E, Moldovan A, Tetean R . Small versus Large Iron Oxide Magnetic Nanoparticles: Hyperthermia and Cell Uptake Properties. Molecules. 2016; 21(10). PMC: 6274490. DOI: 10.3390/molecules21101357. View

10.

Laurent S, Dutz S, Hafeli U, Mahmoudi M . Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci. 2011; 166(1-2):8-23. DOI: 10.1016/j.cis.2011.04.003. View

11.

Kumar C, Mohammad F . Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv Drug Deliv Rev. 2011; 63(9):789-808. PMC: 3138885. DOI: 10.1016/j.addr.2011.03.008. View

12.

Osial M, Rybicka P, Pekala M, Cichowicz G, Cyranski M, Krysinski P . Easy Synthesis and Characterization of Holmium-Doped SPIONs. Nanomaterials (Basel). 2018; 8(6). PMC: 6027423. DOI: 10.3390/nano8060430. View

13.

Das P, Colombo M, Prosperi D . Recent advances in magnetic fluid hyperthermia for cancer therapy. Colloids Surf B Biointerfaces. 2018; 174:42-55. DOI: 10.1016/j.colsurfb.2018.10.051. View

14.

Meng L, Ren Q, Meng Q, Zheng Y, He M, Sun S . Trastuzumab modified silica nanoparticles loaded with doxorubicin for targeted and synergic therapy of breast cancer. Artif Cells Nanomed Biotechnol. 2018; 46(sup3):S556-S563. DOI: 10.1080/21691401.2018.1501380. View

15.

Suriyanto , Ng E, Kumar S . Physical mechanism and modeling of heat generation and transfer in magnetic fluid hyperthermia through Néelian and Brownian relaxation: a review. Biomed Eng Online. 2017; 16(1):36. PMC: 5364696. DOI: 10.1186/s12938-017-0327-x. View

16.

Wu M, Huang S . Magnetic nanoparticles in cancer diagnosis, drug delivery and treatment. Mol Clin Oncol. 2017; 7(5):738-746. PMC: 5649002. DOI: 10.3892/mco.2017.1399. View

17.

Vu T, Claret F . Trastuzumab: updated mechanisms of action and resistance in breast cancer. Front Oncol. 2012; 2:62. PMC: 3376449. DOI: 10.3389/fonc.2012.00062. View

18.

Silva A, Oliveira T, Mamani J, Malheiros S, Malavolta L, Pavon L . Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int J Nanomedicine. 2011; 6:591-603. PMC: 3107718. DOI: 10.2147/IJN.S14737. View

19.

GILCHRIST R, MEDAL R, SHOREY W, HANSELMAN R, Parrott J, Taylor C . Selective inductive heating of lymph nodes. Ann Surg. 1957; 146(4):596-606. PMC: 1450524. DOI: 10.1097/00000658-195710000-00007. View

20.

Lachowicz D, Kaczynska A, Wirecka R, Kmita A, Szczerba W, Bodzon-Kulakowska A . A Hybrid System for Magnetic Hyperthermia and Drug Delivery: SPION Functionalized by Curcumin Conjugate. Materials (Basel). 2018; 11(12). PMC: 6317039. DOI: 10.3390/ma11122388. View